Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.

References 31

1. 1.

   World Health Organization, “Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)” (World Health Organization, 2020).

   Not in our library

2. 2.

   World Health Organization, Coronavirus disease (COVID-19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 1 April 2020.

   Not in our library

3. 3.

   Su S.., Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24, 490–502 (2016 ).

   Not in our library10.1016/j.tim.2016.03.003

4. 4.

   Zhang Y.-Z., Holmes E. C., A genomic perspective on the origin and emergence of SARS-CoV-2. Cell 181, 223–227 (2020 ).

   Not in our library10.1016/j.cell.2020.03.035

5. 5.

   Cui J., Li F., Shi Z.-L., Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181–192 (2019 ).

   Not in our library10.1038/s41579-018-0118-9

6. 6.
   Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses · 2020

   No notice
7. 7.

   Auslander N., Wolf Y. I., Shabalina S. A., Koonin E. V., A unique insert in the genomes of high-risk human papillomaviruses with a predicted dual role in conferring oncogenic risk. F1000 Res. 8, 1000 (2019 ).

   Not in our library10.12688/f1000research.19590.1

8. 8.

   You J.., Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Gen. Virol. 86, 3303–3310 (2005 ).

   Not in our library10.1099/vir.0.81076-0

9. 9.

   Cokol M., Nair R., Rost B., Finding nuclear localization signals. EMBO Rep. 1, 411–415 (2000 ).

   Not in our library10.1093/embo-reports/kvd092

10. 10.
    The Coronavirus Nucleocapsid Is a Multifunctional Protein · 2014

    No notice
11. 11.

    Wurm T.., Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division. J. Virol. 75, 9345–9356 (2001 ).

    Not in our library10.1128/jvi.75.19.9345-9356.2001

12. 12.

    Chen H., Wurm T., Britton P., Brooks G., Hiscox J. A., Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell. J. Virol. 76, 5233–5250 (2002 ).

    Not in our library10.1128/jvi.76.10.5233-5250.2002

13. 13.

    Pei Y.., Functional mapping of the porcine reproductive and respiratory syndrome virus capsid protein nuclear localization signal and its pathogenic association. Virus Res. 135, 107–114 (2008 ).

    Not in our library10.1016/j.virusres.2008.02.012

14. 14.

    Rowland R. R. R.., Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: Absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J. Virol. 79, 11507–11512 (2005 ).

    Not in our library10.1128/jvi.79.17.11507-11512.2005

15. 15.

    Wrapp D.., Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020 ).

    Not in our library10.1126/science.abb2507

16. 16.

    Bosch B. J.., Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. U.S.A. 101, 8455–8460 (2004 ).

    Not in our library10.1073/pnas.0400576101

17. 17.

    Chan W.-E., Chuang C.-K., Yeh S.-H., Chang M.-S., Chen S. S.-L., Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus. J. Virol. 80, 3225–3237 (2006 ).

    Not in our library10.1128/jvi.80.7.3225-3237.2006

18. 18.

    Du L.., The spike protein of SARS-CoV—A target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226–236 (2009 ).

    Not in our library10.1038/nrmicro2090

19. 19.

    Lu L.., Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067 (2014 ).

    Not in our library10.1038/ncomms4067

20. 20.

    Lai A. L., Millet J. K., Daniel S., Freed J. H., Whittaker G. R., The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner. J. Mol. Biol. 429, 3875–3892 (2017 ).

    Not in our library10.1016/j.jmb.2017.10.017

21. 21.

    Millet J. K., Whittaker G. R., Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology 517, 3–8 (2018 ).

    Not in our library10.1016/j.virol.2017.12.015

22. 22.

    Wan Y., Shang J., Graham R., Baric R. S., Li F., Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94, e00127-20 (2020 ).

    Not in our library10.1128/jvi.00127-20

23. 23.

    Wang N.., Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 23, 986–993 (2013 ).

    Not in our library10.1038/cr.2013.92

24. 24.

    Katoh K., Standley D. M., MAFFT multiple sequence alignment software version 7: Improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013 ).

    Not in our library10.1093/molbev/mst010

25. 25.

    Pedregosa F.., Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011 ).

    Not in our library

26. 26.
    FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments · 2010

    No notice
27. 27.

    Li F., Li W., Farzan M., Harrison S. C., Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864–1868 (2005 ).

    Not in our library10.1126/science.1116480

28. 28.

    Lan J.., Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020 ).

    Not in our library10.1038/s41586-020-2180-5

29. 29.

    Walls A. C.., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020 ).

    Not in our library10.1016/j.cell.2020.02.058

30. 30.

    Berman H. M.., The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000 ).

    Not in our library10.1093/nar/28.1.235

31. 31.

    Schrödinger LLC, The PyMOL Molecular Graphics System (Version 2.0, Schrödinger LLC).

    Not in our library

Cited by papers we hold 5

• SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence · 2023
  No notice
• COVID-19: Characteristics and Therapeutics · 2021
  No notice
• Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities · 2021
  Not checked
• SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia · 2021
  Not checked
• Restriction of SARS-CoV-2 replication by targeting programmed −1 ribosomal frameshifting · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.